Cargando…

A cautionary note on the selectivity of oncolytic poxviruses

BACKGROUND: Oncolytic viruses selectively infect cancer cells while avoiding infection of normal cells. Usually, selectivity is demonstrated by injecting a virus into tumor-bearing mice and observing infection and lysis of tumor cells without infection of other tissues. The general view is that this...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Bingtao, Guo, Zong Sheng, Bartlett, David L, Liu, Jia, McFadden, Grant, Shisler, Joanna L, Roy, Edward J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375109/
https://www.ncbi.nlm.nih.gov/pubmed/30805315
http://dx.doi.org/10.2147/OV.S189832
_version_ 1783395307765104640
author Tang, Bingtao
Guo, Zong Sheng
Bartlett, David L
Liu, Jia
McFadden, Grant
Shisler, Joanna L
Roy, Edward J
author_facet Tang, Bingtao
Guo, Zong Sheng
Bartlett, David L
Liu, Jia
McFadden, Grant
Shisler, Joanna L
Roy, Edward J
author_sort Tang, Bingtao
collection PubMed
description BACKGROUND: Oncolytic viruses selectively infect cancer cells while avoiding infection of normal cells. Usually, selectivity is demonstrated by injecting a virus into tumor-bearing mice and observing infection and lysis of tumor cells without infection of other tissues. The general view is that this selectivity is due to tropisms of the virus. However, apparent selectivity could be due to accessibility. For example, intravenously injected virus may not gain access to cells within the central nervous system (CNS) because of the blood–brain barrier. PURPOSE: We tested the CNS safety of two oncolytic poxviruses that have been demonstrated to be safe for treatment of peripheral tumors (vaccinia virus vvDD-IL15-Rα and myxoma virus vMyx-IL15Rα-tdTr). METHODS: Two poxviruses were tested for selectivity in vitro and in vivo. RESULTS: Both viruses infected glioma cells in vitro. In vivo, both viruses infected glioma cells and did not infect neurons when injected into a tumor or into the normal striatum. However, viral gene expression was observed in ependymal cells lining the ventricles, implying that these poxviruses were not as selective as originally predicted. For vvDD-IL15-Rα, some tumor-bearing mice died soon after virus treatment. If the same titer of vvDD-IL15-Rα was injected directly into the lateral cerebral ventricle of nontumor-bearing mice, it was uniformly fatal. Infection of ependymal cells, subventricular cells, and meninges was widespread. On the other hand, vMyx-IL15Rα-tdTr only transiently infected ependymal cells and was safe even when injected directly into the lateral cerebral ventricles. The two poxviruses also differed in their infection of dendritic cells; vvDD-IL15-Rα infected dendritic cells and lysed them but vMyx-IL15Rα-tdTr did not. CONCLUSION: Vaccinia virus vvDD-IL15-Rα is very promising for treating cancer types outside of the brain. However, for cancers located within the brain, myxoma virus vMyx-IL15Rα-tdTr offers a safer alternative.
format Online
Article
Text
id pubmed-6375109
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63751092019-02-25 A cautionary note on the selectivity of oncolytic poxviruses Tang, Bingtao Guo, Zong Sheng Bartlett, David L Liu, Jia McFadden, Grant Shisler, Joanna L Roy, Edward J Oncolytic Virother Original Research BACKGROUND: Oncolytic viruses selectively infect cancer cells while avoiding infection of normal cells. Usually, selectivity is demonstrated by injecting a virus into tumor-bearing mice and observing infection and lysis of tumor cells without infection of other tissues. The general view is that this selectivity is due to tropisms of the virus. However, apparent selectivity could be due to accessibility. For example, intravenously injected virus may not gain access to cells within the central nervous system (CNS) because of the blood–brain barrier. PURPOSE: We tested the CNS safety of two oncolytic poxviruses that have been demonstrated to be safe for treatment of peripheral tumors (vaccinia virus vvDD-IL15-Rα and myxoma virus vMyx-IL15Rα-tdTr). METHODS: Two poxviruses were tested for selectivity in vitro and in vivo. RESULTS: Both viruses infected glioma cells in vitro. In vivo, both viruses infected glioma cells and did not infect neurons when injected into a tumor or into the normal striatum. However, viral gene expression was observed in ependymal cells lining the ventricles, implying that these poxviruses were not as selective as originally predicted. For vvDD-IL15-Rα, some tumor-bearing mice died soon after virus treatment. If the same titer of vvDD-IL15-Rα was injected directly into the lateral cerebral ventricle of nontumor-bearing mice, it was uniformly fatal. Infection of ependymal cells, subventricular cells, and meninges was widespread. On the other hand, vMyx-IL15Rα-tdTr only transiently infected ependymal cells and was safe even when injected directly into the lateral cerebral ventricles. The two poxviruses also differed in their infection of dendritic cells; vvDD-IL15-Rα infected dendritic cells and lysed them but vMyx-IL15Rα-tdTr did not. CONCLUSION: Vaccinia virus vvDD-IL15-Rα is very promising for treating cancer types outside of the brain. However, for cancers located within the brain, myxoma virus vMyx-IL15Rα-tdTr offers a safer alternative. Dove Medical Press 2019-02-11 /pmc/articles/PMC6375109/ /pubmed/30805315 http://dx.doi.org/10.2147/OV.S189832 Text en © 2019 Tang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Tang, Bingtao
Guo, Zong Sheng
Bartlett, David L
Liu, Jia
McFadden, Grant
Shisler, Joanna L
Roy, Edward J
A cautionary note on the selectivity of oncolytic poxviruses
title A cautionary note on the selectivity of oncolytic poxviruses
title_full A cautionary note on the selectivity of oncolytic poxviruses
title_fullStr A cautionary note on the selectivity of oncolytic poxviruses
title_full_unstemmed A cautionary note on the selectivity of oncolytic poxviruses
title_short A cautionary note on the selectivity of oncolytic poxviruses
title_sort cautionary note on the selectivity of oncolytic poxviruses
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375109/
https://www.ncbi.nlm.nih.gov/pubmed/30805315
http://dx.doi.org/10.2147/OV.S189832
work_keys_str_mv AT tangbingtao acautionarynoteontheselectivityofoncolyticpoxviruses
AT guozongsheng acautionarynoteontheselectivityofoncolyticpoxviruses
AT bartlettdavidl acautionarynoteontheselectivityofoncolyticpoxviruses
AT liujia acautionarynoteontheselectivityofoncolyticpoxviruses
AT mcfaddengrant acautionarynoteontheselectivityofoncolyticpoxviruses
AT shislerjoannal acautionarynoteontheselectivityofoncolyticpoxviruses
AT royedwardj acautionarynoteontheselectivityofoncolyticpoxviruses
AT tangbingtao cautionarynoteontheselectivityofoncolyticpoxviruses
AT guozongsheng cautionarynoteontheselectivityofoncolyticpoxviruses
AT bartlettdavidl cautionarynoteontheselectivityofoncolyticpoxviruses
AT liujia cautionarynoteontheselectivityofoncolyticpoxviruses
AT mcfaddengrant cautionarynoteontheselectivityofoncolyticpoxviruses
AT shislerjoannal cautionarynoteontheselectivityofoncolyticpoxviruses
AT royedwardj cautionarynoteontheselectivityofoncolyticpoxviruses